MASM
BMY icon

MH & Associates Securities Management’s Bristol-Myers Squibb BMY Stock Holding History

MH & Associates Securities Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Sell
21,593
-309
-1% -$17.7K 1.12% 35
2026
Q1 		$1.33M Hold
21,902
– – 1.16% 35
2025
Q4 		$1.18M Buy
+21,902
New +$1.05M 0.96% 42

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MH & Associates Securities Management's BMY Position: Q2 2026 in Review

MH & Associates Securities Management reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, selling an estimated $17.7K and leaving 21,593 shares worth $1.24M. The position accounts for 1.12% of the portfolio, ranked #35.

MH & Associates Securities Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.33M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MH & Associates Securities Management held 21,593 shares of Bristol-Myers Squibb worth $1.24M as of Q2 2026.
  • MH & Associates Securities Management sold 309 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.7K.
  • Bristol-Myers Squibb made up 1.12% of MH & Associates Securities Management's portfolio in Q2 2026, its #35 holding.
  • MH & Associates Securities Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • MH & Associates Securities Management's Bristol-Myers Squibb position peaked at $1.33M in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MH & Associates Securities Management's 13F filing for Q2 2026, filed 28 Jul 2026.